Panacea Biotec informs about disclosure

28 Dec 2024 Evaluate

In continuation to intimation letter dated June 22, 2024, wherein it has informed about the incorporation of wholly owned subsidiary company, Panacea Biotec Inc. (‘PB Inc.’) by the Company’s material subsidiary, Panacea Biotec Pharma (‘PBPL’) and an investment of US$ 75,000 (~Rs.6.23 million) made by PBPL in the shares of common stock of PB Inc. In this regard, Panacea Biotec has further informed that on December 27, 2024, PBPL made further investment of US$ 9,25,000 (~Rs.7.92 Crore) in PB Inc. as subscription for 9,25,00,000 shares of common stock of PB Inc. at a price of US$ 0.01 per share. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated 13th July, 2023, are given in Annexure A to this letter.

The above information is a part of company’s filings submitted to BSE.

Panacea Biotec Share Price

429.45 -22.60 (-5.00%)
27-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1861.70
Dr. Reddys Lab 1389.35
Cipla 1506.15
Lupin 2228.00
Zydus Lifesciences 972.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.